Acasti Pharma DPO Ratio 2011-2026 | ACST

Annual DPO Ratio Acasti Pharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	4.39 K	-	-	-	-	1.68 K	383	400	292	39.5 K	-

All numbers in USD currency

Maximum	Minimum	Average
39.5 K	292	7.77 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Amphastar Pharmaceuticals AMPH	28.5	$ 25.92	-0.86 %	$ 1.26 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
BioXcel Therapeutics BTAI	2.52 K	$ 1.84	1.66 %	$ 4.66 M	USA
Aytu BioScience AYTU	186	$ 2.66	-1.85 %	$ 16.7 M	USA
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Coherus BioSciences CHRS	53.7	$ 2.04	28.3 %	$ 192 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Biogen BIIB	65.4	$ 171.89	-1.1 %	$ 25 B	USA
Baudax Bio BXRX	140	-	0.59 %	$ 63 K	USA
Corcept Therapeutics Incorporated CORT	550	$ 44.32	7.3 %	$ 4.58 B	USA
Arena Pharmaceuticals ARNA	142	-	-6.81 %	$ 3.04 B	USA